Advertisement Recombinant Incorporation of Amino Acids Into Proteins - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
close icon

Peptide Synthesis and Pharmaceutical Intermediates

More info about

Recombinant Incorporation of Amino Acids Into Proteins

Mutant or modified aminoacyl-tRNA synthetases (aaRS) have been used to charge non-natural amino acids to the corresponding tRNA, which incorporates them into polypeptides or proteins during recombinant synthesis. As azido homoalanine (Aha) is a structure analogue of methionine (Met), Met has been replaced effectively by Aha in proteins by the native methionyl tRNA synthetase of E. coli, [1]. A modified yeast phenylalanyl-tRNA synthetase was prepared by introduction of a T415G or T415A mutation in its α-subunit; specific residues in tryptophanyl-tRNA synthetase and methionyl-tRNA synthetase are also identified, where mutagenesis results in specificity for non-natural aminoacyl-tRNA molecules. Further developments and inventions have been done to specifically incorporate a vast number of Click components into practically any protein.

Once the azido function has been built into the protein sequence, conjugation with a large number of diverse partners including PEG-polymers, dyes, cofactors, antibodies, small molecules, toxins, additional proteins and peptides opens a wide field with many different applications from therapeutics to diagnostics.

For Incorporation of Aha by Chemical Synthesis into Peptides or other Organic Molecules the following Building Blocks are available:

  • BAA1800 Boc-L-Aha-OH*CHA CAS: 120042-08-2net
  • BAA1805 Boc-D-Aha-OH*CHA
  • FAA6620 Fmoc-L-Aha-OH CAS: 942518-20-9
  • FAA6810 Fmoc-D-Aha-OH
  • ZAA5700 Z-L-Aha-OH*DCHA
Quick Contact Recombinant Incorporation of Amino Acids Into Proteins